| Title : Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications - Lentz_2005_Am.J.Pharmacogenomics_5_21 |
| Author(s) : Lentz F , Tran A , Rey E , Pons G , Treluyer JM |
| Ref : Am J Pharmacogenomics , 5 :21 , 2005 |
| Abstract : |
| PubMedSearch : Lentz_2005_Am.J.Pharmacogenomics_5_21 |
| PubMedID: 15727486 |
| Title : Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications - Lentz_2005_Am.J.Pharmacogenomics_5_21 |
| Author(s) : Lentz F , Tran A , Rey E , Pons G , Treluyer JM |
| Ref : Am J Pharmacogenomics , 5 :21 , 2005 |
| Abstract : |
| PubMedSearch : Lentz_2005_Am.J.Pharmacogenomics_5_21 |
| PubMedID: 15727486 |
| Title : Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications - Lentz_2005_Am.J.Pharmacogenomics_5_21 |
| Author(s) : Lentz F , Tran A , Rey E , Pons G , Treluyer JM |
| Ref : Am J Pharmacogenomics , 5 :21 , 2005 |
| Abstract : |
| PubMedSearch : Lentz_2005_Am.J.Pharmacogenomics_5_21 |
| PubMedID: 15727486 |